Surveillance Barriers

How it works

Risks & contraindications

Other

Highlighted claims

• Barriers are defined as obstacles that hinder malaria surveillance activities in community pharmacies and over-the-counter medicine sellers. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Provider-level barriers include increased workload, delayed service delivery, operational costs, client financial burden, and reduced business revenue. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• System-level barriers include limited awareness of reporting requirements, administrative burden, low motivation, and weak public-private coordination. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• The review anticipates that heterogeneity in outlet classification, regulatory scope, epidemiology, and surveillance architecture will complicate comparisons across countries. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Provider motivation to participate in surveillance is shaped by willingness, client requests, clinical judgement, personal conviction, desire to treat febrile illness, and sociocultural orientation. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol